Pneumonia

Benefit observed even in adults with levels of aerobic activity below guideline recommendations

Showdown of HFNC and helmet- and face mask-based modalities in meta-analysis

Advisors unanimously recommend agency approve drug combination for healthcare-associated cases

Sulbactam-durlobactam under consideration for cases caused by Acinetobacter spp.

Potential harm seen among three trials testing different approaches

FDA grants EUA to anti-C5a antibody for patients on mechanical ventilation, ECMO

One big benefit amid similar overall results for high-dose prophylaxis in critically ill patients

Death by day 28 occurred in 6% of those who received the drug in the ICU vs 12% of placebo group

A 67-year-old man presented to the ED appearing ill with complaints of productive cough, dyspnea, pleuritic chest pain, and fever for the past 5 days. Can you diagnose the patient?

Randomized trial suggests this common practice doesn't help

Mechanical ventilation use should follow guidelines for any other pneumonia, say researchers

Stick with a 6-mg dose, as giving more can be harmful in this group, RECOVERY researchers advise

Also in TTHealthWatch: a new therapy for advanced melanoma

Newer vaccines have the potential to further reduce pneumococcal disease, say researchers